The immunosuppressive effect of MYCN expression in cancers, including neuroblastoma and lung cancer, is well known [45–47], and Masso-Valles et al. reported that MYCN inhibition may be a potential cancer immunotherapy [45]. Here, MYCN is linked to lung carcinoma.